Glaukos
Glaukos Corporation, a pioneering force in the ophthalmic industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1998, Glaukos has established itself as a leader in developing innovative therapies for glaucoma and other eye diseases. The company is renowned for its unique micro-invasive surgical procedures, particularly the iStent® technology, which has transformed the treatment landscape for patients suffering from glaucoma. With a commitment to advancing eye care, Glaukos has achieved notable milestones, including the first FDA approval of a micro-invasive glaucoma surgery device. The company’s dedication to research and development has positioned it at the forefront of the ophthalmic market, making significant contributions to improving patient outcomes and enhancing the quality of life for those affected by vision-related conditions.
DitchCarbon Score
How does Glaukos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Glaukos's score of 33 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Glaukos's reported carbon emissions
In 2024, Glaukos Corporation reported total carbon emissions of approximately 3,058,600 kg CO2e, comprising 523,300 kg CO2e from Scope 1 and 2,535,300 kg CO2e from Scope 2 emissions. This marks an increase from 2023, when emissions were about 2,734,800 kg CO2e, with Scope 1 emissions at 575,400 kg CO2e and Scope 2 emissions at 2,159,400 kg CO2e. In 2022, the company recorded total emissions of approximately 1,929,600 kg CO2e, with Scope 1 at 569,400 kg CO2e and Scope 2 at 1,360,200 kg CO2e. Glaukos has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 emissions to near zero by 2025. This initiative reflects the company's dedication to sustainability and aligns with industry standards for climate action. The reduction targets were established in their 2022 Sustainability Report, indicating a proactive approach to mitigating climate impact. As of now, Glaukos has not disclosed any Scope 3 emissions data, which typically encompasses indirect emissions from the supply chain and product use. The company’s emissions data is not cascaded from any parent organisation, ensuring that their reported figures are independently sourced.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 569,400 | 000,000 | 000,000 |
| Scope 2 | 1,360,200 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Glaukos is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
